Status:
TERMINATED
Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Colon Tumors
Rectum Tumors
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinot...
Eligibility Criteria
Inclusion
- Peritoneal seedings coming from colon, rectum, pseudomyxoma (appendix), peritoneum (mesothelioma and serous tumors), or endocrine tumors.
- No extra-abdominal metastases
- Good general status (American Society of Anesthesiologists Physical Status score \[ASA\] 1 or 2)
- Signed consent
Exclusion
- Tumor seedings coming from other origins
- Huge peritoneal carcinomatosis (peritoneal score \> 25, except for pseudomyxomas)
- Peritoneal carcinomatosis progressing rapidly
- Presence of extra-abdominal metastases
- Patients presenting contraindications to the use of oxaliplatin or irinotecan
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00180960
Start Date
June 1 2003
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave-Roussy
Villejuif, France, 94800